A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease | Nature Reviews Neurology
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain | Nature Reviews Neurology
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease - Rao - 2020 - Aging Cell - Wiley Online Library
The amyloid state and its association with protein misfolding diseases | Nature Reviews Molecular Cell Biology
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology
A new era for understanding amyloid structures and disease | Nature Reviews Molecular Cell Biology
Nrn ad posters- nature
Pathophysiology and treatment of systemic amyloidosis | Nature Reviews Nephrology
The amyloid hypothesis of Alzheimer's disease at 25 years | EMBO Molecular Medicine
Amyloid assembly and disassembly | Journal of Cell Science
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies | Nature Reviews Neurology
Amyloid-β-independent regulators of tau pathology in Alzheimer disease | Nature Reviews Neuroscience
The Amyloid State of Proteins in Human Diseases - ScienceDirect
Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles - Nanoscale (RSC Publishing)
A new era for understanding amyloid structures and disease | Nature Reviews Molecular Cell Biology
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Alzheimer's disease | Nature Reviews Disease Primers
From amyloid-β to receptor endocytosis | Nature Reviews Neuroscience
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics | Nature Reviews Drug Discovery
The amyloid interactome: Exploring protein aggregation
